POVTENZI
Live / Applied — New application — not yet assigned to an examiner (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 20 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99714539
- Mark type
- Design + words
- Filed
- 20 Mar 2026
- Attorney of record
- Lisa M. Tittemore
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 20 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 20 Mar 2026 — NEW APPLICATION ENTERED